Cargando…
Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles
OBJECTIVE: The objectives of this study were to evaluate the bioequivalence of Quesero extended release (Quesero XR) tablets and Seroquel extended release (Seroquel XR) tablets under fasting and fed conditions and to determine the effect of food on the pharmacokinetic (PK) properties of Quesero XR o...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319427/ https://www.ncbi.nlm.nih.gov/pubmed/30643391 http://dx.doi.org/10.2147/DDDT.S182965 |
_version_ | 1783385059418439680 |
---|---|
author | Huang, Xiaomei Zhang, Suhua Ma, Yanxia Yang, Heng He, Chuan Tian, Rufang Mei, Han Liu, Lipeng Zhang, Bikui |
author_facet | Huang, Xiaomei Zhang, Suhua Ma, Yanxia Yang, Heng He, Chuan Tian, Rufang Mei, Han Liu, Lipeng Zhang, Bikui |
author_sort | Huang, Xiaomei |
collection | PubMed |
description | OBJECTIVE: The objectives of this study were to evaluate the bioequivalence of Quesero extended release (Quesero XR) tablets and Seroquel extended release (Seroquel XR) tablets under fasting and fed conditions and to determine the effect of food on the pharmacokinetic (PK) properties of Quesero XR or Seroquel XR in Chinese healthy volunteers. METHODS: A single-site, randomized, open-label, two-period crossover design with a 10-day washout period was conducted in 20 subjects under the fed and fasting studies. A single oral dose of 200 mg Quesero XR or Seroquel XR was given to the subjects after an overnight fast of 10 hours. Blood samples were taken at scheduled time spots from 0 hour pre dose to 36 hours post dose. Plasma concentrations of quetiapine were measured by a validated ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method. The PK parameters were calculated by non-compartment analysis using Phoenix WinNonlin software. RESULTS: On both conditions, no significant differences were found among the main PK parameters of the two preparations by analysis of variance (P>0.05); the Wilcoxon test of maximum peak plasma concentration (T(max)) showed no significant differences (P>0.05); the 90% confidence limit (CL) of lnC(max), lnAUC(0→36), and lnAUC(0→∞) fell within the acceptable range of 80%–125%. As compared with the fasting state, the T(max) was advanced and the mean maximum plasma concentration (C(max)), AUC(0→36), and AUC(0→∞) were also increased in the fed state; the geometric mean ratio and 90% CI of the main PK parameters fell outside the range of the CIs; analysis of variance showed significant differences in the other PK parameters except for apparent total clearance after oral administration (clearance rate; P<0.05). CONCLUSION: The two formulations of Quesero XR and Seroquel XR are bioequivalent under both fasting and fed conditions, and food may affect the PK profiles by increasing the rate and extent of absorption of Quesero XR or Seroquel XR in Chinese healthy volunteers. |
format | Online Article Text |
id | pubmed-6319427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-63194272019-01-14 Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles Huang, Xiaomei Zhang, Suhua Ma, Yanxia Yang, Heng He, Chuan Tian, Rufang Mei, Han Liu, Lipeng Zhang, Bikui Drug Des Devel Ther Original Research OBJECTIVE: The objectives of this study were to evaluate the bioequivalence of Quesero extended release (Quesero XR) tablets and Seroquel extended release (Seroquel XR) tablets under fasting and fed conditions and to determine the effect of food on the pharmacokinetic (PK) properties of Quesero XR or Seroquel XR in Chinese healthy volunteers. METHODS: A single-site, randomized, open-label, two-period crossover design with a 10-day washout period was conducted in 20 subjects under the fed and fasting studies. A single oral dose of 200 mg Quesero XR or Seroquel XR was given to the subjects after an overnight fast of 10 hours. Blood samples were taken at scheduled time spots from 0 hour pre dose to 36 hours post dose. Plasma concentrations of quetiapine were measured by a validated ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method. The PK parameters were calculated by non-compartment analysis using Phoenix WinNonlin software. RESULTS: On both conditions, no significant differences were found among the main PK parameters of the two preparations by analysis of variance (P>0.05); the Wilcoxon test of maximum peak plasma concentration (T(max)) showed no significant differences (P>0.05); the 90% confidence limit (CL) of lnC(max), lnAUC(0→36), and lnAUC(0→∞) fell within the acceptable range of 80%–125%. As compared with the fasting state, the T(max) was advanced and the mean maximum plasma concentration (C(max)), AUC(0→36), and AUC(0→∞) were also increased in the fed state; the geometric mean ratio and 90% CI of the main PK parameters fell outside the range of the CIs; analysis of variance showed significant differences in the other PK parameters except for apparent total clearance after oral administration (clearance rate; P<0.05). CONCLUSION: The two formulations of Quesero XR and Seroquel XR are bioequivalent under both fasting and fed conditions, and food may affect the PK profiles by increasing the rate and extent of absorption of Quesero XR or Seroquel XR in Chinese healthy volunteers. Dove Medical Press 2018-12-31 /pmc/articles/PMC6319427/ /pubmed/30643391 http://dx.doi.org/10.2147/DDDT.S182965 Text en © 2019 Huang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Huang, Xiaomei Zhang, Suhua Ma, Yanxia Yang, Heng He, Chuan Tian, Rufang Mei, Han Liu, Lipeng Zhang, Bikui Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles |
title | Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles |
title_full | Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles |
title_fullStr | Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles |
title_full_unstemmed | Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles |
title_short | Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles |
title_sort | bioequivalence of two quetiapine extended release tablets in chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319427/ https://www.ncbi.nlm.nih.gov/pubmed/30643391 http://dx.doi.org/10.2147/DDDT.S182965 |
work_keys_str_mv | AT huangxiaomei bioequivalenceoftwoquetiapineextendedreleasetabletsinchinesehealthyvolunteersunderfastingandfedconditionsandeffectsoffoodonpharmacokineticprofiles AT zhangsuhua bioequivalenceoftwoquetiapineextendedreleasetabletsinchinesehealthyvolunteersunderfastingandfedconditionsandeffectsoffoodonpharmacokineticprofiles AT mayanxia bioequivalenceoftwoquetiapineextendedreleasetabletsinchinesehealthyvolunteersunderfastingandfedconditionsandeffectsoffoodonpharmacokineticprofiles AT yangheng bioequivalenceoftwoquetiapineextendedreleasetabletsinchinesehealthyvolunteersunderfastingandfedconditionsandeffectsoffoodonpharmacokineticprofiles AT hechuan bioequivalenceoftwoquetiapineextendedreleasetabletsinchinesehealthyvolunteersunderfastingandfedconditionsandeffectsoffoodonpharmacokineticprofiles AT tianrufang bioequivalenceoftwoquetiapineextendedreleasetabletsinchinesehealthyvolunteersunderfastingandfedconditionsandeffectsoffoodonpharmacokineticprofiles AT meihan bioequivalenceoftwoquetiapineextendedreleasetabletsinchinesehealthyvolunteersunderfastingandfedconditionsandeffectsoffoodonpharmacokineticprofiles AT liulipeng bioequivalenceoftwoquetiapineextendedreleasetabletsinchinesehealthyvolunteersunderfastingandfedconditionsandeffectsoffoodonpharmacokineticprofiles AT zhangbikui bioequivalenceoftwoquetiapineextendedreleasetabletsinchinesehealthyvolunteersunderfastingandfedconditionsandeffectsoffoodonpharmacokineticprofiles |